CD34 and acute myeloid leukemia: Early studies showed that in both high and standard risk leukaemias, as with AML, populations with the HSC-like immunophenotype CD34+CD19− contained the only source of ALL stem cells (Cobaleda et al, 2000; Cox et al, 2004).